XLV – Health Care Select Sector SPDR® Fund
Health Care Select Sector SPDR® Fund (XLV) is a Health ETF, issued by State Street Investment Management, $47B in assets, 0.09% expense ratio.
Returns as of Oct 23, 2026: 1 week +1.5%, 1 year +25.1%.
Tracks Health Care sector index. Invests 95% in pharmaceuticals, equipment, providers, biotech, life sciences tools, and healthcare technology.
Top holdings
- LLY – Eli Lilly and Company, 15.9%
- JNJ – Johnson & Johnson, 10.0%
- ABBV – AbbVie Inc, 7.9%
- MRK – Merck & Company Inc, 5.6%
- UNH – UnitedHealth Group Incorporated, 5.6%
- TMO – Thermo Fisher Scientific Inc, 3.8%
- AMGN – Amgen Inc, 3.7%
- GILD – Gilead Sciences Inc, 2.8%
- ABT – Abbott Laboratories, 2.8%
- PFE – Pfizer Inc, 2.6%
- ISRG – Intuitive Surgical Inc, 2.4%
- DHR – Danaher Corporation, 2.1%
- VRTX – Vertex Pharmaceuticals Inc, 2.1%
- BMY – Bristol-Myers Squibb Company, 1.9%
- CVS – CVS Health Corp, 1.8%
- MCK – McKesson Corporation, 1.7%
- MDT – Medtronic PLC, 1.7%
- SYK – Stryker Corporation, 1.6%
- ELV – Elevance Health Inc, 1.5%
- CI – Cigna Corp, 1.3%
- REGN – Regeneron Pharmaceuticals Inc, 1.2%
- MRNA – Moderna Inc, 1.2%
- HCA – HCA Healthcare, Inc., 1.1%
- BSX – Boston Scientific Corp, 1.0%
- COR – Cencora Inc., 1.0%